NEW GMS & OUTCOMES FRAMEWORK – Good news for patients, Practice income and your...

In the third article in a series of five, Paul Midgley of the Healthcare Partnership looks at how the ‘Quality & Outcomes’ framework (QOF)...

Financial Health Check

AS EMPLOYERS CONTINUE TO BATTLE with the ever-increasing challenge of maintaining and increasing employee commitment, it is essential that they demonstrate just how and...

Surviving Assessment Centres

Nothing is as straightforward as it used to be – and Recruitment is no different! The good old days of two-stage interviews and job...

The Matrix – DECODING THE NHS

THE PRESCRIBING ADVISERS in Primary care represent one of the industry’s biggest challenges. In the second part of this topic, Omar Ali explores some...

Improving Access to Medicines

THE NATIONAL PLAN: a plan for investment, a plan for reform aimed to give the public a health service which: • Is designed around...

Cannabis: Good for your health?

IN THIS DAY AND AGE, where political correct-ness and morality rule, society in general has become more informed about most topics, be it cancer...

Group Therapy for the Uninitiated

The selling process is changing; an increasing number of customer contacts are now being made in group situations. However, many sales people are concerned...

The joys of independence

IT IS NOT ALWAYS REALISED that some of the big-name pharmaceutical companies such as Boehringer Ingelheim, Napp Pharmaceuticals and Servier are still privately-owned. This...

Cultural Intelligence

HAVE YOU EVER WONDERED why we select candidates for Medical Representative positions largely on their personality and potential ability to develop relationships with customers...

First Line Management Development

  Getting your first line management role can be quite a challenge. Most first line managers will have spent several years being developed for...

Latest articles

People sitting around a desk with laptops and tablets to show Pharma drug approvals round-up: UK, Europe, US

What’s been authorised? UK, Europe, US drug approvals

Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
hands holding smart phones to show Digital interventions for behaviour change

Digital interventions for behaviour change

New NICE guidance looks at digital interventions for behaviour change and suggests that these interventions such as apps, wearable devices and online programmes and...
image of red and blue heart on purple background to show Acute aortic dissection is a 'ticking time bomb'

Acute aortic dissection is a ‘ticking time bomb’

Safety body calls for earlier recognition of ‘ticking time bomb’ aortic dissection to prevent deaths as its new report reveals that up to half...

Popular articles

People sitting around a desk with laptops and tablets to show Pharma drug approvals round-up: UK, Europe, US

What’s been authorised? UK, Europe, US drug approvals

Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
black and white photo of Craig Bradley to show Key publications to impact the UK access environment in 2020

Key publications to impact the UK access environment in 2020

Craig Bradley, Commercial Lead Rare GI at Takeda, PM Society Chair & PM Society Market Access Interest Group Lead, looks at key publications to...
image of lungs, the left lung is bordered by orange, the right by blue to show AstraZeneca's Tagrisso▼ (osimertinib) rejected by NICE for use in NHS England

AstraZeneca’s Tagrisso▼ (osimertinib) rejected by NICE for use in NHS England

The National Institute for Health and Care Excellence (NICE) has published final guidance that does not recommend AstraZeneca's Tagrisso▼ (osimertinib) for use within NHS...
Image of man and woman sat in waiting room holding their stomachs to show NICE rejects Janssen's Stelara for moderate to severe ulcerative colitis

NICE rejects Janssen’s Stelara for moderate to severe ulcerative colitis

The National Institute for Health and Care Excellence (NICE) has not recommended ustekinumab, Janssen's Stelara, for treating moderately to severely active ulcerative colitis in...
Illustration of people meeting at a table that looks like a pill to show Tiofarma admits illegal role in fludrocortisone anti-competitive agreement

Tiofarma admits illegal role in fludrocortisone anti-competitive agreement

Tiofarma has admitted that it took part in a fludrocortisone anti-competitive agreement that resulted in significant price hikes for the essential medicine. This means that...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription